Low on-treatment levels of serum soluble CD8 (sCD8) predict better outcomes in advanced non-small cell lung cancer patients treated with atezolizumab.
Cancer Immunol Immunother
; 72(6): 1853-1863, 2023 Jun.
Article
in En
| MEDLINE
| ID: mdl-36688998
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
CD8 Antigens
/
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Cancer Immunol Immunother
Journal subject:
ALERGIA E IMUNOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: